81

Kennedy RS, Konok GP, Bounous G, Baruchel S, Lee TD
The use of a whey protein concentrate in the treatment of patients with metastatic carcinoma: a phase I-II clinical study
Anticancer Res 1995 Nov-Dec;15(6B):2643-9 (Clinical Study, Abstract)
Source: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=8669840&dopt=Abstract

82

Fahey JW, Zhang Y, Talalay P
Broccoli sprouts: an exceptionally rich source of inducers of enzymes that protect against chemical carcinogens
Proc Natl Acad Sci U S A 1997 Sep 16;94(19):10367-72 (Animal Study, Abstract | Full Text)
Source: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=9294217&dopt=Abstract
Free full text article: http://www.ncbi.nlm.nih.gov/entrez/utils/fref.fcgi?http://www.pnas.org/cgi/pmidlookup?view=full&pmid=9294217

83

Xin X, Yang S, Kowalski J, Gerritsen ME
Peroxisome proliferator-activated receptor gamma ligands are potent inhibitors of angiogenesis in vitro and in vivo
J Biol Chem 1999 Mar 26;274(13):9116-21 (Cell Culture Study | Animal Study, Abstract | Full Text)
Source: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=10085162&dopt=Abstract
Free full text article: http://www.ncbi.nlm.nih.gov/entrez/utils/fref.fcgi?http://www.jbc.org/cgi/pmidlookup?view=full&pmid=10085162

84

Murata T, He S, Hangai M, Ishibashi T, Xi XP, Kim S, Hsueh WA, Ryan SJ, Law RE, Hinton DR
Peroxisome proliferator-activated receptor-gamma ligands inhibit choroidal neovascularization
Invest Ophthalmol Vis Sci 2000 Jul;41(8):2309-17 (Cell Culture Study | Animal Study, Abstract)
Source: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=10892878&dopt=Abstract
Free full text article: http://www.iovs.org/cgi/content/full/41/8/2309

85

Gilbertson-Beadling S, Powers EA, Stamp-Cole M, Scott PS, Wallace TL, Copeland J, Petzold G, Mitchell M, Ledbetter S, Poorman R
The tetracycline analogs minocycline and doxycycline inhibit angiogenesis in vitro by a non-metalloproteinase-dependent mechanism
Cancer Chemother Pharmacol 1995;36(5):418-24 (Cell Culture Study, Abstract)
Source: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=7543375&dopt=Abstract

86

87

Joussen AM, Kruse FE, Volcker HE, Kirchhof B
Topical application of methotrexate for inhibition of corneal angiogenesis
Graefes Arch Clin Exp Ophthalmol 1999 Nov;237(11):920-7 (Animal Study, Abstract)
Source: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=10541903&dopt=Abstract

88

Guba M, von Breitenbuch P, Steinbauer M, Koehl G, Flegel S, Hornung M, Bruns CJ, Zuelke C, Farkas S, Anthuber M, Jauch KW, Geissler EK
Rapamycin inhibits primary and metastatic tumor growth by antiangiogenesis: involvement of vascular endothelial growth factor
Nat Med 2002 Feb;8(2):128-35 (Animal Study, Abstract)
Source: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=11821896&dopt=Abstract

89

Yoshiji H, Kuriyama S, Kawata M, Yoshii J, Ikenaka Y, Noguchi R, Nakatani T, Tsujinoue H, Fukui H
The angiotensin-I-converting enzyme inhibitor perindopril suppresses tumor growth and angiogenesis: possible role of the vascular endothelial growth factor
Clin Cancer Res 2001 Apr;7(4):1073-8 (Animal Study, Abstract | Full Text)
Source: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=11309359&dopt=Abstract
Free full text article: http://www.ncbi.nlm.nih.gov/entrez/utils/fref.fcgi?
http://clincancerres.aacrjournals.org/cgi/pmidlookup?view=full&pmid=11309359

90

Verheul HM, Panigrahy D, Yuan J, D'Amato RJ
Combination oral antiangiogenic therapy with thalidomide and sulindac inhibits tumour growth in rabbits
Br J Cancer 1999 Jan;79(1):114-8 (Animal Study, Abstract)
Source: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=10408702&dopt=Abstract

91

Brewer GJ, Dick RD, Grover DK, LeClaire V, Tseng M, Wicha M, Pienta K, Redman BG, Jahan T, Sondak VK, Strawderman M, LeCarpentier G, Merajver SD
Treatment of metastatic cancer with tetrathiomolybdate, an anticopper, antiangiogenic agent: Phase I study
Clin Cancer Res 2000 Jan;6(1):1-10 (Clinical Study, Abstract | Full Text)
Source: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=10656425&dopt=Abstract
Free full text article: http://www.ncbi.nlm.nih.gov/entrez/utils/fref.fcgi?
http://clincancerres.aacrjournals.org/cgi/pmidlookup?view=full&pmid=10656425

92

Hayes RL, Koslow M, Hiesiger EM, Hymes KB, Hochster HS, Moore EJ, Pierz DM, Chen DK, Budzilovich GN, Ransohoff J
Improved long term survival after intracavitary interleukin-2 and lymphokine-activated killer cells for adults with recurrent malignant glioma
Cancer 1995 Sep 1;76(5):840-52 (Clinical Study, Abstract)
Source: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=8625188&dopt=Abstract

93

Plautz GE, Barnett GH, Miller DW, Cohen BH, Prayson RA, Krauss JC, Luciano M, Kangisser DB, Shu S
Systemic T cell adoptive immunotherapy of malignant gliomas
J Neurosurg 1998 Jul;89(1):42-51 (Clinical Study, Abstract)
Source: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=9647171&dopt=Abstract

94

95

Pecora AL, Rizvi N, Cohen GI, Meropol NJ, Sterman D, Marshall JL, Goldberg S, Gross P, O'Neil JD, Groene WS, Roberts MS, Rabin H, Bamat MK, Lorence RM
Phase I trial of intravenous administration of PV701, an oncolytic virus, in patients with advanced solid cancers
J Clin Oncol 2002 May 1;20(9):2251-66 (Clinical Study, Abstract)
Source: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=11980996&dopt=Abstract

96

Schneider T, Gerhards R, Kirches E, Firsching R
Preliminary results of active specific immunization with modified tumor cell vaccine in glioblastoma multiforme
J Neurooncol 2001 May;53(1):39-46 (Clinical Study, Abstract)
Source: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=11678429&dopt=Abstract

97

Batliwalla FM, Bateman BA, Serrano D, Murray D, Macphail S, Maino VC, Ansel JC, Gregersen PK, Armstrong CA
A 15-year follow-up of AJCC stage III malignant melanoma patients treated postsurgically with Newcastle disease virus (NDV) oncolysate and determination of alterations in the CD8 T cell repertoire
Mol Med 1998 Dec;4(12):783-94
Source: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=9990864&dopt=Abstract

Wilcox ME, Yang W, Senger D, Rewcastle NB, Morris DG, Brasher PM, Shi ZQ, Johnston RN, Nishikawa S, Lee PW, Forsyth PA
Reovirus as an oncolytic agent against experimental human malignant gliomas
J Natl Cancer Inst 2001 Jun 20;93(12):903-12 (Cell Culture Study | Animal Study, Abstract)
Source: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=11416111&dopt=Abstract

Rampling R, Cruickshank G, Papanastassiou V, Nicoll J, Hadley D, Brennan D, Petty R, MacLean A, Harland J, McKie E, Mabbs R, Brown M
Toxicity evaluation of replication-competent herpes simplex virus (ICP 34.5 null mutant 1716) in patients with recurrent malignant glioma
Gene Ther 2000 May;7(10):859-66 (Clinical Study, Abstract)
Source: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=10845724&dopt=Abstract

Gromeier M, Lachmann S, Rosenfeld MR, Gutin PH, Wimmer E.
Intergeneric poliovirus recombinants for the treatment of malignant glioma.
Proc Natl Acad Sci U S A 2000 Jun 6;97(12):6803-8 (Cell Culture Study | Animal Study, Abstract | Full Text)
Source: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=10841575&dopt=Abstract
Free full text article: http://www.ncbi.nlm.nih.gov/entrez/utils/fref.fcgi?http://www.pnas.org/cgi/pmidlookup?view=full&pmid=10841575